The performance of semi-quantitative differential PCR is similar to that of real-time PCR for the detection of the MYCN gene in neuroblastomas

Autor(es)

A.C.M.F. Souza ^[1] ; D.R.V. Souza ^[2] ; S.S. Sanabani ^[3] ; R.R. Giorgi ^[4] ; I. Bendit ^[5]

Afiliação do(s) autor(es)

^[1] Universidade de São Paulo. Hospital das Clínicas. Disciplina de Hematologia e Hemoterapia

^[2] Universidade de São Paulo. Hospital das Clínicas. Disciplina de Hematologia e Hemoterapia

^[3] Hemocentro. Fundação Pro-Sangue - Brasil

^[4] Universidade de São Paulo. Faculdade de Medicina. Departamento de Endocrinologia e Metabologia - Brasil

^[5] Universidade de São Paulo. Hospital das Clínicas. Disciplina de Hematologia e Hemoterapia

• Tipo de documento: Artigo Científico
• Fonte: Brazilian Journal of Medical and Biological Research; v. 42, n. 9, p. 791-795, 2009-09-00.

Resumo

Amplification of the MYCN gene in neuroblastomas is a potent biological marker of highly aggressive tumors, which are invariably fatal unless sound clinical management is applied. To determine the usefulness of semi-quantitative differential PCR (SQ-PCR) for accurate quantification of MYCN gene copy number, we evaluated the analytical performance of this method by comparing the results obtained with it for 101 tumor samples of neuroblastoma to that obtained by absolute and relative real-time PCR. Similar results were obtained for 100 (99%) samples, no significant difference was detected between the median log10 MYCN copy number (1.53 by SQ-PCR versus 1.55 by absolute real-time PCR), and the results of the two assays correlated closely (r = 0.8, Pearson correlation; P < 0.001). In the comparison of SQ-PCR and relative real-time PCR, SQ-PCR versus relative real-time PCR concordant results were found in 100 (99%) samples, no significant difference was found in median log10 MYCN copy number (1.53 by SQ-PCR versus 1.27 by relative real-time PCR), and the results of the two assays correlated closely (r = 0.8, Pearson correlation; P < 0.001). These findings indicate that the performance of SQ-PCR was comparable to that of real-time PCR for the amplification and quantification of MYCN copy number. Thus, SQ-PCR can be reliably used as an alternative assay in laboratories without facilities for real-time PCR. (AU)

• Processo FAPESP: 03/09696-6 - Caracterização molecular dos neuroblastomas através da amplificação dos genes MYCN, DDX1 e NAG e da expressão em nivel de RNA de MYCN, TRK-A e DDX1: estudo retrospectivo de amostras provenientes de pacientes acompanhados no Protocolo Neuro IX-2000
• Beneficiário: Israel Bendit
• Modalidade de apoio: Auxílio à Pesquisa - Regular